SynthesisLangenbeck's archives of surgery2026
Accelerated enhanced recovery after colorectal surgery with early discharge: A systematic review and meta-analysis.
Synthesis in Langenbeck's archives of surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate whether accelerated enhanced recovery protocols increase rates of readmission, emergency department (ED) revisits, reoperation, or complications following colorectal surgery.
methodsThe protocol was prospectively registered in PROSPERO (CRD42024621268). A systematic search was perfomed in major databases including MEDLINE, EMBASE, and Cochrane databases. Primary outcomes was 30-day readmission rates. Secondary outcomes were ED revisits, reoperations, and complications. Risk of bias was assessed using the ROBINS-I tool.
resultsThirteen studies involving 40,589 patients were included, with 1,783 patients in the aERPs group and 38,806 in the ERPs group. The meta-analysis revealed no statistically significant differences in 30-day readmission rates (OR 0.85, 95% CI 0.55–1.29, p = 0.43), ED revisits (OR 0.95, 95% CI 0.42–2.18, p = 0.91), reoperations (OR 0.97, 95% CI 0.61–1.54, p = 0.90), or complications (OR 0.47, 95% CI 0.17–1.32, p = 0.15).
conclusionsAccelerated ERPs with early discharge strategies, appear safe and feasible for selected patients undergoing minimally invasive colorectal surgery, with no increased risk of readmissions, ED visits, reoperations, or complications. Future high-quality randomized controlled trials are needed to refine patient selection criteria and optimize implementation of aERPs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.